BioSpace News Archive

Drug Development

Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis

Data expected in late 2018 from Phase 3 studies of VX-659, tezacaftor and ivacaftor in people with one F508del mutation and one minimal function mutation and in people with two F508del mutations

September 6, 2018
·
9 min read
Business

Wiley Reports First Quarter Fiscal 2019 Results

John Wiley & Sons, Inc. (NYSE:JWA) (NYSE:JWB), a global research communications and education company, today announced results for the first quarter ended July 31, 2018.

September 6, 2018
·
20 min read
Genetown

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding

MPM Capital and Novartis Venture Fund co-led financing to advance lead program targeting microRNA modulating proteins for the treatment of cancer

September 6, 2018
·
7 min read
Business

St. Anthony’s Triathlon Opens Registration Oct. 1 for 36th Annual Race Weekend

St. Petersburg’s Gulf Coast waterfront, downtown and picturesque neighborhoods, will see thousands of athletes swim, bike and run in the 36th Annual St. Anthony’s Triathlon April 26-28, 2019.

September 6, 2018
·
4 min read
Business

Ultrasound-Guided Peripheral IV Access Risks Patient Safety

A new white paper discusses the prevalence of ultrasound-guided peripheral intravenous (UGPIV) procedures, the challenges associated with obtaining UGPIV access, and solutions for hospitals to improve patient safety while lowering costs.

September 6, 2018
·
3 min read
Pharm Country

Spheryx’s xSight Selected as Finalist for the 2018 R&D 100 Awards

Spheryx, Inc. announced today that their xSight has been named a finalist for the 2018 R&D 100 Award.

September 6, 2018
·
1 min read
Pharm Country

Geneia Listed as a Sample Vendor in Three Gartner 2018 Hype Cycle Reports

Geneia, a healthcare analytic solutions and services company that is simplifying the evolution to value-based care, was named in three Gartner 2018 Hype Cycle reports

September 6, 2018
·
3 min read
Business

Gary Winer Joins LENSAR, Inc. Board of Directors

Company Continues to Add Strategic Leadership, Building on Momentum Behind its Technology’s Expansion in the Global Refractive Cataract Market

September 6, 2018
·
2 min read
Pharm Country

CVS Health Earns NCQA Health Information Products Certification in Pharmacy Benefits

Recognition underscores company’s commitment to providing comprehensive pharmacy benefit information to CVS Caremark members

September 6, 2018
·
2 min read
Business

Outcome Health Announces Partnership with ZERO to Raise Awareness for Prostate Cancer

Organizations Collaborate to Deliver Nationwide Campaign During Prostate Cancer Awareness Month

September 6, 2018
·
2 min read